In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...
Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...
A flood of off-lease EVs will soon start hitting dealers, driving down prices.
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the ...
By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...
A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...
The EMA has started its review of Daiichi Sankyo and AstraZeneca's Enhertu as a first-line therapy for HER2-positive breast ...
Chemists at UCLA are showing that some of organic chemistry’s most famous “rules” aren’t as unbreakable as once thought. By ...
With aggressive breast cancer, 78-year-old couldn’t have surgery or chemotherapy: How did doctors save her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results